Rockwell Medical Q2 FY26 net loss narrows 20% to USD 1.2 million; net sales rise 11% to USD 17.8 million

• Rockwell Medical posted Q2 net sales of USD 17.8 million, up 11% year over year.
• Net loss narrowed to USD 1.2 million; gross margin rose 2 percentage points to 18%.
• Adjusted EBITDA loss under non-GAAP held at USD 0.2 million.
• Cash, cash equivalents, and available-for-sale investments totaled USD 24.8 million at June 30.
• Reiterated 2026 outlook: net sales USD 70 million-USD 75 million; adjusted EBITDA USD 1 million-USD 2 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rockwell Medical Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260813588314) on August 13, 2026, and is solely responsible for the information contained therein.